Daptomycin versus Glycopeptides for the Treatment of Enterococcus faecium Bacteraemia: A Cohort Study

Background: Ampicillin resistant and glycopeptide susceptible Enterococcus faecium bloodstream infection (GSEF-BSI) incidence has risen. However, the treatment of choice remains unknown. Daptomycin use for the treatment of enterococcal infections has increased, despite effectiveness and safety conce...

Descripción completa

Detalles Bibliográficos
Autores principales: Echeverría-Esnal, Daniel, Sorli, Luisa, Prim, Nuria, Martin-Ontiyuelo, Clara, Horcajada, Juan Pablo, Grau, Santiago
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232223/
https://www.ncbi.nlm.nih.gov/pubmed/34198646
http://dx.doi.org/10.3390/antibiotics10060716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232223/
https://www.ncbi.nlm.nih.gov/pubmed/34198646
http://dx.doi.org/10.3390/antibiotics10060716

Ejemplares similares